Picture

Northwestern Medicine
​Breakthroughs for Physicians

​​
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties

< BACK TO RESEARCH IN RHEUMATOLOGY

October 2024

RHEUMATOLOGY

SOCIAL DETERMINANTS OF HEALTH AND DISPARITIES IN LUPUS NEPHRITIS OUTCOMES

Rosalind Ramsey-Goldman, MD, contributed to a study which investigated the influence of social determinants of health (SDoH) on the outcomes of lupus nephritis (LN), a complication of systemic lupus erythematosus. LN disproportionately affects young women, particularly those from minority racial and ethnic backgrounds. Disparities in LN incidence, treatment and outcomes have been well-documented, but the underlying causes remain poorly understood.

The primary objective of the study was to estimate the pooled odds of poor LN outcomes in patients with adverse SDoH compared to those without adverse SDoH. In the analysis, poor LN included mortality, cardiovascular disease and end-stage kidney disease.

The secondary objective was to examine the odds of poor LN outcomes within specific SDoH domains, such as individual, healthcare, community and health behaviors. The pooled odds of poor outcomes were calculated using a random effects model.
​
The study aimed to develop a framework that sheds light on the multidimensional impact of SDoH on LN outcomes. This involved analyzing the observed combined pooled odds of poor outcomes in subsets of patients with two or more adverse SDoH and comparing them to the expected additive and multiplicative pooled odds.
​
Read the full study to discover the results>

Dr. Ramsey-Goldman
Rosalind Ramsey-Goldman, MD, the Gallagher Research Professor of Rheumatology at Northwestern Medicine

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​
Call 844.344.6663
Find an NM Rheumatologist

You May Also Like

Pregnant belly

November 2023

RHEUMATOLOGY
Case Report: Pregnancy With Lupus and Lupus Nephritis
Dr. Ruderman

October 2024

RHEUMATOLOGY
Treating Concurrent Plaque Psoriasis and Psoriatic Arthritis
Dr. Jawaheer

October 2024

RHEUMATOLOGY
Biomarkers May Help Predict Rheumatoid Arthritis Changes During Pregnancy

Northwestern Medicine Breakthroughs for Physicians

About Us     Terms of Use     Privacy Policy     How to Vote for U.S. News & World Report Best Hospitals
© 2025 Northwestern Medicine® and Northwestern Memorial HealthCare. 
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University
Connect with us
[email protected]
International physicians, contact [email protected]
  • Home
  • Specialties
    • Cardiovascular >
      • Research
      • Clinical Breakthroughs
      • News
    • Endocrinology >
      • Clinical Breakthroughs In Endocrinology
      • Research In Endocrinology
      • News
    • ENT (Otolaryngology) >
      • Clinical Breakthroughs
      • Research
      • News
    • Gastroenterology >
      • Clinical Breakthroughs
      • Research
      • News
    • Geriatrics >
      • Clinical Breakthroughs
      • Research
      • News
    • Neurosciences >
      • Rare and Complex Brain Tumors
      • Research
      • COVID-19 and Neurosciences
      • News
      • Clinical Breakthroughs
    • OB-GYN >
      • Clinical Breakthroughs
      • Research
      • News
    • Oncology >
      • Clinical Breakthroughs
      • Research
      • News
    • Ophthalmology >
      • Clinical Breakthroughs
      • Research
      • News
    • Organ Transplant >
      • Clinical Breakthroughs
      • Research
      • News
    • Orthopaedics >
      • Clinical Breakthroughs
      • Research
      • News
    • Psychiatry >
      • Clinical Breakthroughs
      • Research
      • News
    • Pulmonary >
      • Clinical Breakthroughs
      • Research
      • News
    • Rehabilitation >
      • Clinical Breakthroughs
      • News
    • Rheumatology >
      • Clinical Breakthroughs
      • Research
      • News
    • Urology >
      • Clinical Breakthroughs
      • Research
      • News
  • CME
  • REFERRALS
    • Refer to NM Cardiovascular
    • Refer to NM Neurosciences
    • Refer to Other Specialties